Peptide backbone modifications of amyloid β (1–40) impact fibrillation behavior and neuronal toxicity
Abstract Fibril formation of amyloid β (Aβ) peptides is one of the key molecular events connected to Alzheimer’s disease. The pathway of formation and mechanism of action of Aβ aggregates in biological systems is still object of very active research. To this end, systematic modifications of the Phe1...
Main Authors: | Benedikt Schwarze, Alexander Korn, Corinna Höfling, Ulrike Zeitschel, Martin Krueger, Steffen Roßner, Daniel Huster |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2021-12-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-021-03091-4 |
Similar Items
-
Probing the Influence of Single-Site Mutations in the Central Cross-β Region of Amyloid β (1–40) Peptides
by: Jacob Fritzsch, et al.
Published: (2021-12-01) -
Mechanistic Basis for Ribosomal Peptide Backbone Modifications
by: Shi-Hui Dong, et al.
Published: (2019-04-01) -
Editorial: Oligomerization and fibrillation of amyloid peptides: Mechanism, toxicity and inhibition
by: Zhenyu Qian, et al.
Published: (2022-09-01) -
Electrochemical quantification of the Alzheimer’s disease amyloid-β (1–40) using amyloid-β fibrillization promoting peptide
by: Satoshi Fujii, et al.
Published: (2015-12-01) -
Identification of the primary peptide contaminant that inhibits fibrillation and toxicity in synthetic amyloid-β42.
by: Daniel J Adams, et al.
Published: (2017-01-01)